2023 Form 5500 filing — Lotte Biologics 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015100257NAL0048753520001) for Lotte Biologics 401(K) Plan, reported by Lotte Biologics Usa, LLC under EIN 88-3288202 and plan number 001. It reports 250 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015100257NAL0048753520001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Lotte Biologics Usa, LLC
- EIN
- 88-3288202
- Plan number
- 001
- Location
- East Syracuse, NY
- Participants
- 250
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $55,783,235
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $55,783,235
- Employer contributions
- $2,250,284
- Participant contributions
- $4,231,037
- Total income / additions
- $60,357,841
- Benefits paid
- $4,591,663
- Administrative expenses
- -$17,057
- Total expenses
- $4,574,606
- Net increase / (decrease)
- $55,783,235
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Strategic Advisors, Inc. | ADVISOR | $8,944 | not reported in the loaded dataset |
| Fidelity Investments Institutional | RECORDKEEPER | -$26,001 | $0 |